{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:54:08Z","timestamp":1790902448628,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"DOI":"10.1007\/s12010-026-05920-6","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:06:35Z","timestamp":1790841995000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Enhanced Anti-inflammatory Effects of 18\u03b2-Glycyrrhetinic Acid and Hesperetin for the Treatment of Psoriasis: Evidence from LPS-stimulated RAW264.7 Cells and Imiquimod-induced Psoriasis Mouse Model"],"prefix":"10.1007","author":[{"given":"Chintan R.","family":"Khunt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4988-069X","authenticated-orcid":false,"given":"Deepti K.","family":"Jani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"issue":"19","key":"5920_CR1","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong, A. W., & Read, C. (2020). Pathophysiology, clinical presentation, and treatment of psoriasis: A review. JAMA, 323(19), 1945\u20131960.","journal-title":"JAMA"},{"issue":"9997","key":"5920_CR2","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","volume":"386","author":"WH Boehncke","year":"2015","unstructured":"Boehncke, W. H., & Schon, M. P. (2015). Psoriasis. Lancet, 386(9997), 983\u2013994.","journal-title":"Lancet"},{"key":"5920_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.743180","volume":"8","author":"G Damiani","year":"2021","unstructured":"Damiani, G., Bragazzi, N. L., Karimkhani Aksut, C., Wu, D., Alicandro, G., McGonagle, D., Guo, C., Dellavalle, R., Grada, A., Wong, P., La Vecchia, C., Tam, L.-S., Cooper, K. D., & Naghavi, M. (2021). The global, regional, and national burden of psoriasis: Results and insights from the global burden of disease 2019 study. Frontiers in Medicine, 8, Article 743180.","journal-title":"Frontiers in Medicine"},{"issue":"2","key":"5920_CR4","doi-asserted-by":"publisher","first-page":"530","DOI":"10.3390\/ijms19020530","volume":"19","author":"MA Boutet","year":"2018","unstructured":"Boutet, M. A., Nerviani, A., Gallo Afflitto, G., & Pitzalis, C. (2018). Role of the IL-23\/IL-17 axis in psoriasis and psoriatic arthritis: The clinical importance of its divergence in skin and joints. International Journal of Molecular Sciences, 19(2), 530.","journal-title":"International Journal of Molecular Sciences"},{"issue":"5","key":"5920_CR5","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/jid.2009.399","volume":"130","author":"S Kagami","year":"2010","unstructured":"Kagami, S., Rizzo, H. L., Lee, J. J., Koguchi, Y., & Blauvelt, A. (2010). Circulating Th17, Th22, and Th1 cells are increased in psoriasis. Journal of Investigative Dermatology, 130(5), 1373\u20131383.","journal-title":"Journal of Investigative Dermatology"},{"issue":"2","key":"5920_CR6","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jaci.2016.03.048","volume":"138","author":"T Fujiyama","year":"2016","unstructured":"Fujiyama, T., Ito, T., Umayahara, T., Ikeya, S., Tatsuno, K., Funakoshi, A., Hashizume, H., & Tokura, Y. (2016). Topical application of a vitamin D3 analogue and corticosteroid to psoriasis plaques decreases skin infiltration of TH17 cells and their ex vivo expansion. Journal of Allergy and Clinical Immunology, 138(2), 517\u2013528.","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"5920_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01323","volume":"9","author":"MP Sch\u00f6n","year":"2018","unstructured":"Sch\u00f6n, M. P., & Erpenbeck, L. (2018). The interleukin-23\/interleukin-17 axis links adaptive and innate immunity in psoriasis. Frontiers in Immunology, 9, Article 1323.","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"5920_CR8","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41392-023-01655-6","volume":"8","author":"J Guo","year":"2023","unstructured":"Guo, J., Zhang, H., Lin, W., Lu, L., Su, J., & Chen, X. (2023). Signaling pathways and targeted therapies for psoriasis. Signal Transduction and Targeted Therapy, 8(1), 437.","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"4","key":"5920_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13040781","volume":"13","author":"Y Li","year":"2025","unstructured":"Li, Y., Cheng, Y., Cai, Y., Duan, Z., Xu, H., Huang, Y., Ma, X., Xin, X., & Yin, L. (2025). Novel small-molecule treatment and emerging biological therapy for psoriasis. Biomedicines, 13(4), Article 781.","journal-title":"Biomedicines"},{"issue":"4","key":"5920_CR10","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s13555-020-00409-4","volume":"10","author":"DM Balak","year":"2020","unstructured":"Balak, D. M., Gerdes, S., Parodi, A., & Salgado-Boquete, L. (2020). Long-term safety of oral systemic therapies for psoriasis: A comprehensive review of the literature. Dermatologic Therapy, 10(4), 589\u2013613.","journal-title":"Dermatologic Therapy"},{"key":"5920_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120762","volume":"604","author":"T Guo","year":"2021","unstructured":"Guo, T., Lu, J., Fan, Y., Zhang, Y., Yin, S., Sha, X., & Feng, N. (2021). TPGS assists the percutaneous administration of curcumin and glycyrrhetinic acid coloaded functionalized ethosomes for the synergistic treatment of psoriasis. International Journal of Pharmaceutics, 604, Article 120762.","journal-title":"International Journal of Pharmaceutics"},{"key":"5920_CR12","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jconrel.2016.10.004","volume":"243","author":"A Jain","year":"2016","unstructured":"Jain, A., Doppalapudi, S., Domb, A. J., & Khan, W. (2016). Tacrolimus and curcumin co-loaded liposphere gel: Synergistic combination towards management of psoriasis. Journal of Controlled Release, 243, 132\u2013145.","journal-title":"Journal of Controlled Release"},{"issue":"5","key":"5920_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/plants12051086","volume":"12","author":"P Shinu","year":"2023","unstructured":"Shinu, P., Gupta, G. L., Sharma, M., Khan, S., Goyal, M., Nair, A. B., Kumar, M., Soliman, W. E., Rahman, A., Attimarad, M., Venugopala, K. N., & Altaweel, A. A. A. (2023). Pharmacological features of 18\u03b2-glycyrrhetinic acid: A pentacyclic triterpenoid of therapeutic potential. Plants, 12(5), Article 1086.","journal-title":"Plants"},{"issue":"14","key":"5920_CR14","doi-asserted-by":"publisher","first-page":"7726","DOI":"10.1021\/jf2013265","volume":"59","author":"CY Wang","year":"2011","unstructured":"Wang, C. Y., Kao, T. C., Lo, W. H., & Yen, G. C. (2011). Glycyrrhizic acid and 18\u03b2-glycyrrhetinic acid modulate lipopolysaccharide-induced inflammatory response by suppression of NF-\u03baB through PI3K p110\u03b4 and p110\u03b3 inhibitions. Journal of Agricultural and Food Chemistry, 59(14), 7726\u20137733.","journal-title":"Journal of Agricultural and Food Chemistry"},{"key":"5920_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.681525","volume":"12","author":"Y Feng","year":"2021","unstructured":"Feng, Y., Mei, L., Wang, M., Huang, Q., & Huang, R. (2021). Anti-inflammatory and pro-apoptotic effects of 18beta-glycyrrhetinic acid in vitro and in vivo models of rheumatoid arthritis. Frontiers in Pharmacology, 12, Article 681525.","journal-title":"Frontiers in Pharmacology"},{"issue":"1","key":"5920_CR16","doi-asserted-by":"publisher","first-page":"1980456","DOI":"10.1155\/2020\/1980456","volume":"2020","author":"H Chen","year":"2020","unstructured":"Chen, H., Liu, H., Tang, B., Chen, Y., Han, L., Yu, J., Yan, Y., & Lu, C. (2020). The protective effects of 18\u03b2-Glycyrrhetinic acid on imiquimod-induced psoriasis in mice via suppression of mTOR\/STAT3 signaling. Journal of Immunology Research, 2020(1), 1980456.","journal-title":"Journal of Immunology Research"},{"issue":"3","key":"5920_CR17","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/ptr.5256","volume":"29","author":"H Parhiz","year":"2015","unstructured":"Parhiz, H., Roohbakhsh, A., Soltani, F., Rezaee, R., & Iranshahi, M. (2015). Antioxidant and anti-inflammatory properties of the citrus flavonoids hesperidin and hesperetin: An updated review of their molecular mechanisms and experimental models. Phytotherapy Research, 29(3), 323\u2013331.","journal-title":"Phytotherapy Research"},{"key":"5920_CR18","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/472897","author":"CH Shih","year":"2012","unstructured":"Shih, C. H., Lin, L. H., Hsu, H. T., Wang, K. H., Lai, C. Y., Chen, C. M., & Ko, W. C. (2012). Hesperetin, a selective phosphodiesterase 4 inhibitor, effectively suppresses ovalbumin\u2010induced airway hyperresponsiveness without influencing xylazine\/ketamine\u2010induced anesthesia. Evidence-Based Complementary and Alternative Medicine. https:\/\/doi.org\/10.1155\/2012\/472897","journal-title":"Evidence-Based Complementary and Alternative Medicine"},{"issue":"12","key":"5920_CR19","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s12272-019-01200-6","volume":"42","author":"N Wang","year":"2019","unstructured":"Wang, N., Geng, C., Sun, H., Wang, X., Li, F., & Liu, X. (2019). Hesperetin ameliorates lipopolysaccharide-induced acute lung injury in mice through regulating the TLR4\u2013MyD88\u2013NF-\u03baB signaling pathway. Archives of Pharmacal Research, 42(12), 1063\u20131070.","journal-title":"Archives of Pharmacal Research"},{"key":"5920_CR20","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.fitote.2017.07.016","volume":"121","author":"HW Ding","year":"2017","unstructured":"Ding, H. W., Huang, A. L., Zhang, Y. L., Li, B., Huang, C., Ma, T. T., Meng, X. M., & Li, J. (2017). Design, synthesis and biological evaluation of hesperetin derivatives as potent anti-inflammatory agent. Fitoterapia, 121, 212\u2013222.","journal-title":"Fitoterapia"},{"issue":"6","key":"5920_CR21","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s40262-013-0040-2","volume":"52","author":"FE Stuurman","year":"2013","unstructured":"Stuurman, F. E., Nuijen, B., Beijnen, J. H., & Schellens, J. H. (2013). Oral anticancer drugs: Mechanisms of low bioavailability and strategies for improvement. Clinical Pharmacokinetics, 52(6), 399\u2013414.","journal-title":"Clinical Pharmacokinetics"},{"issue":"4","key":"5920_CR22","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.nut.2011.07.027","volume":"28","author":"V Pallares","year":"2012","unstructured":"Pallares, V., Calay, D., Ced\u00f3, L., Castell-Auv\u00ed, A., Raes, M., Pinent, M., Ard\u00e9vol, A., Arola, L., & Blay, M. (2012). Additive, antagonistic, and synergistic effects of procyanidins and polyunsaturated fatty acids over inflammation in RAW 264.7 macrophages activated by lipopolysaccharide. Nutrition, 28(4), 447\u2013457.","journal-title":"Nutrition"},{"issue":"9","key":"5920_CR23","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","volume":"182","author":"L Van Der Fits","year":"2009","unstructured":"Van Der Fits, L., Mourits, S., Voerman, J. S., Kant, M., Boon, L., Laman, J. D., Cornelissen, F., Mus, A. M., Florencia, E., Prens, E. P., & Lubberts, E. (2009). Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis. The Journal of Immunology, 182(9), 5836\u20135845.","journal-title":"The Journal of Immunology"},{"issue":"1","key":"5920_CR24","first-page":"97","volume":"6","author":"N Zhang","year":"2015","unstructured":"Zhang, N., Fu, J. N., & Chou, T. C. (2015). Synergistic combination of microtubule targeting anticancer fludelone with cytoprotective panaxytriol derived from Panax ginseng against MX-1 cells in vitro: Experimental design and data analysis using the combination index method. American Journal of Cancer Research, 6(1), 97.","journal-title":"American Journal of Cancer Research"},{"key":"5920_CR25","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.synres.2018.04.001","volume":"7","author":"TC Chou","year":"2018","unstructured":"Chou, T. C. (2018). The combination index (CI< 1) as the definition of synergism and of synergy claims. Synergy, 7, 49\u201350.","journal-title":"Synergy"},{"issue":"14","key":"5920_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/nu16142343","volume":"16","author":"J Wang","year":"2024","unstructured":"Wang, J., Yao, Y., Yao, T., Shi, Q., Zeng, Y., & Li, L. (2024). Hesperetin alleviated experimental colitis via regulating ferroptosis and gut microbiota. Nutrients, 16(14), Article 2343.","journal-title":"Nutrients"},{"issue":"5","key":"5920_CR27","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/s12276-021-00620-z","volume":"53","author":"L Hao","year":"2021","unstructured":"Hao, L., Mao, Y., Park, J., Kwon, B. M., Bae, E. J., & Park, B. H. (2021). 2\u2032-Hydroxycinnamaldehyde ameliorates imiquimod-induced psoriasiform inflammation by targeting PKM2-STAT3 signaling in mice. Experimental and Molecular Medicine, 53(5), 875\u2013884.","journal-title":"Experimental and Molecular Medicine"},{"issue":"2","key":"5920_CR28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1365-2133.1992.tb07805.x","volume":"126","author":"BS Baker","year":"1992","unstructured":"Baker, B. S., Brent, L., Valdimarsson, H., Powles, A. V., Al-Imara, L., Walker, M., & Fry, L. (1992). Is epidermal cell proliferation in psoriatic skin grafts on nude mice driven by T-cell derived cytokines? British Journal of Dermatology, 126(2), 105\u2013110.","journal-title":"British Journal of Dermatology"},{"key":"5920_CR29","doi-asserted-by":"publisher","DOI":"10.1177\/03946320241260262","volume":"38","author":"L Xu","year":"2024","unstructured":"Xu, L., Jiang, Y., Xu, F., Liu, J., Jiang, Y., Fang, F., & Luo, L. (2024). Deucravacitinib and shikonin combination therapy ameliorates imiquimod-induced psoriasis in mice. International Journal of Immunopathology and Pharmacology, 38, Article 03946320241260262.","journal-title":"International Journal of Immunopathology and Pharmacology"},{"key":"5920_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112561","volume":"138","author":"A Ebrahimi","year":"2024","unstructured":"Ebrahimi, A., Mehrabi, M., Miraghaee, S. S., Mohammadi, P., Kafash, F. F., Delfani, M., & Khodarahmi, R. (2024). Flavonoid compounds and their synergistic effects: Promising approaches for the prevention and treatment of psoriasis with emphasis on keratinocytes\u2013A systematic and mechanistic review. International Immunopharmacology, 138, Article 112561.","journal-title":"International Immunopharmacology"},{"key":"5920_CR31","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.ejmech.2016.07.070","volume":"123","author":"N Polachi","year":"2016","unstructured":"Polachi, N., Bai, G., Li, T., Chu, Y., Wang, X., Li, S., Gu, N., Wu, J., Li, W., Zhang, Y., Zhou, S., Sun, H., & Liu, C. (2016). Modulatory effects of silibinin in various cell signaling pathways against liver disorders and cancer\u2013A comprehensive review. European Journal of Medicinal Chemistry, 123, 577\u2013595.","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"10","key":"5920_CR32","doi-asserted-by":"publisher","first-page":"5306","DOI":"10.3390\/ijms25105306","volume":"25","author":"K Nazimek","year":"2024","unstructured":"Nazimek, K., & Bryniarski, K. (2024). Macrophage functions in psoriasis: Lessons from mouse models. International Journal of Molecular Sciences, 25(10), 5306.","journal-title":"International Journal of Molecular Sciences"},{"issue":"11","key":"5920_CR33","doi-asserted-by":"publisher","first-page":"6973","DOI":"10.4049\/jimmunol.173.11.6973","volume":"173","author":"CH Woo","year":"2004","unstructured":"Woo, C. H., Lim, J. H., & Kim, J. H. (2004). Lipopolysaccharide induces matrix metalloproteinase-9 expression via a mitochondrial reactive oxygen species-p38 kinase-activator protein-1 pathway in Raw 264.7 cells. Journal of Immunology, 173(11), 6973\u20136980.","journal-title":"Journal of Immunology"},{"issue":"1","key":"5920_CR34","doi-asserted-by":"publisher","DOI":"10.1155\/MI\/2006\/16043","volume":"2006","author":"NS Tekin","year":"2006","unstructured":"Tekin, N. S., Ilter, N., Sancak, B., Ozden, M. G., & Gurer, M. A. (2006). Nitric oxide levels in patients with psoriasis treated with methotrexate. Mediators of Inflammation, 2006(1), Article 016043.","journal-title":"Mediators of Inflammation"},{"issue":"3","key":"5920_CR35","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.jid.2021.06.019","volume":"142","author":"RS Gangwar","year":"2022","unstructured":"Gangwar, R. S., Gudjonsson, J. E., & Ward, N. L. (2022). Mouse models of psoriasis: A comprehensive review. Journal of Investigative Dermatology, 142(3), 884\u2013897.","journal-title":"Journal of Investigative Dermatology"},{"key":"5920_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e17315","author":"M Wang","year":"2023","unstructured":"Wang, M., Yin, X., Zeng, Y., Hu, C., Xue, Y., Fang, Q., Qiao, X., Zhao, X., Du, C., Huang, F., & Lin, Y. (2023). Extracts from Seseli mairei Wolff attenuate imiquimod-induced psoriasis-like inflammation by inhibiting Th17 cells. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e17315","journal-title":"Heliyon"},{"key":"5920_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e20151","author":"S Lallo","year":"2023","unstructured":"Lallo, S., Hardianti, B., Djabir, Y. Y., Ismail, I., Indrisari, M., Aswad, M., Hertati, A., Habibie, H., & Hayakawa, Y. (2023). Piper retrofractum ameliorates imiquimod-induced skin inflammation via modulation of TLR4 axis and suppression of NF-\u03baB activity. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e20151","journal-title":"Heliyon"},{"key":"5920_CR38","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1016\/j.biopha.2018.10.062","volume":"109","author":"Y Li","year":"2019","unstructured":"Li, Y., Zhang, G., Chen, M., Tong, M., Zhao, M., Tang, F., Xiao, R., & Wen, H. (2019). Rutaecarpine inhibited imiquimod-induced psoriasis-like dermatitis via inhibiting the NF-\u03baB and TLR7 pathways in mice. Biomedicine & Pharmacotherapy, 109, 1876\u20131883.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"4","key":"5920_CR39","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.3390\/ijms23042112","volume":"23","author":"H Guo","year":"2022","unstructured":"Guo, H., Li, M., & Liu, H. (2022). Selenium-rich yeast peptide fraction ameliorates imiquimod-induced psoriasis-like dermatitis in mice by inhibiting inflammation via MAPK and NF-\u03baB signaling pathways. International Journal of Molecular Sciences, 23(4), 2112.","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"5920_CR40","first-page":"6756138","volume":"2016","author":"P Alvarez","year":"2016","unstructured":"Alvarez, P., & Jensen, L. E. (2016). Imiquimod treatment causes systemic disease in mice resembling generalized pustular psoriasis in an IL-1 and IL-36 dependent manner. Mediators of Inflammation, 2016(1), 6756138.","journal-title":"Mediators of Inflammation"},{"issue":"3","key":"5920_CR41","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.jid.2016.10.024","volume":"137","author":"JE Hawkes","year":"2017","unstructured":"Hawkes, J. E., Gudjonsson, J. E., & Ward, N. L. (2017). The snowballing literature on imiquimod-induced skin inflammation in mice: A critical appraisal. Journal of Investigative Dermatology, 137(3), 546\u2013549.","journal-title":"Journal of Investigative Dermatology"},{"issue":"12","key":"5920_CR42","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1002\/eji.201343801","volume":"43","author":"B Flutter","year":"2013","unstructured":"Flutter, B., & Nestle, F. O. (2013). TLRs to cytokines: Mechanistic insights from the imiquimod mouse model of psoriasis. European Journal of Immunology, 43(12), 3138\u20133146.","journal-title":"European Journal of Immunology"},{"issue":"6","key":"5920_CR43","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.jid.2022.12.013","volume":"143","author":"Q Meng","year":"2023","unstructured":"Meng, Q., Bai, M., Guo, M., Li, Z., Liu, W., Fan, X., Sun, R., Yang, X., Yuan, D., Shi, Y., & Deng, H. (2023). Inhibition of serum-and glucocorticoid-regulated protein kinase-1 aggravates imiquimod-induced psoriatic dermatitis and enhances proinflammatory cytokine expression through the NF-kB pathway. Journal of Investigative Dermatology, 143(6), 954\u2013964.","journal-title":"Journal of Investigative Dermatology"},{"issue":"5","key":"5920_CR44","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.jid.2019.01.006","volume":"139","author":"S Moos","year":"2019","unstructured":"Moos, S., Mohebiany, A. N., Waisman, A., & Kurschus, F. C. (2019). Imiquimod-induced psoriasis in mice depends on the IL-17 signaling of keratinocytes. Journal of Investigative Dermatology, 139(5), 1110\u20131117.","journal-title":"Journal of Investigative Dermatology"},{"issue":"2","key":"5920_CR45","first-page":"116","volume":"102","author":"I Okura","year":"2021","unstructured":"Okura, I., Kamata, M., Asano, Y., Mitsui, A., Shimizu, T., Sato, S., & Tada, Y. (2021). Fingolimod ameliorates imiquimod-induced psoriasiform dermatitis by sequestrating interleukin-17-producing? d T cells in secondary lymph nodes. Journal of Investigative Dermatology, 102(2), 116\u2013125.","journal-title":"Journal of Investigative Dermatology"},{"key":"5920_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111884","volume":"141","author":"T Di","year":"2021","unstructured":"Di, T., Zhao, J., Wang, Y., Han, L., Guo, X., Han, X., Chen, Z., Li, P., & Lu, C. (2021). Tuhuaiyin alleviates imiquimod-induced psoriasis via inhibiting the properties of IL-17-producing cells and remodels the gut microbiota. Biomedicine & Pharmacotherapy, 141, Article 111884.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"03","key":"5920_CR47","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1055\/s-0041-1726681","volume":"11","author":"F Salwa","year":"2021","unstructured":"Salwa, F., Badanthadka, M., & D\u2019Souza, L. (2021). Differential psoriatic effect of imiquimod on BALB\/c and Swiss mice. Journal of Health and Allied Sciences NU, 11(03), 170\u2013177.","journal-title":"Journal of Health and Allied Sciences NU"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05920-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-026-05920-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05920-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:03:35Z","timestamp":1790899415000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-026-05920-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":47,"alternative-id":["5920"],"URL":"https:\/\/doi.org\/10.1007\/s12010-026-05920-6","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"assertion":[{"value":"2 September 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The animal study was carried out with prior approval from the Institutional Animal Ethics Committee (IAEC) of the Department of Pharmaceutical Sciences, Saurashtra University, Rajkot, India (IAEC No. IAEC\/DPS\/SU\/2413), and care of animals complied with the Committee for Control and Supervision of Experiments on Animals (CCSEA) guidelines, Government of India.","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Clinical Trial Number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent to Publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":5,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}